Tech Company Financing Transactions

Cambrian Biopharma Funding Round

Cambrian Biopharma closed a $100 million Series C venture capital round on 10/27/2021. Investors included Anthos Capital, Salt Funds Management and Apeiron Investment Group.

Transaction Overview

Company Name
Announced On
10/27/2021
Transaction Type
Venture Equity
Amount
$100,000,000
Round
Series C
Investors

Anthos Capital (Lead Investor) (Paul Farr)

Salt Funds Management (Lead Investor)

Apeiron Investment Group

Future Ventures

Moore Capital

Proceeds Purpose
The capital from our Series C round equips us to continue advancing our existing pipeline and also partner with more scientific innovators to bring more programs under the Cambrian banner.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
228 Park Ave. South 66643
New York, NY 10003
USA
Phone
Undisclosed
Email Address
Overview
A true partner in the pursuit of expanded healthspan. Cambrian's scientists and company-building experts closely partner with research teams, offering scientific and organizational insights and support for a significant edge in a complex, rapidly evolving field.
Profile
Cambrian Biopharma LinkedIn Company Profile
Social Media
Cambrian Biopharma Company Twitter Account
Company News
Cambrian Biopharma News
Facebook
Cambrian Biopharma on Facebook
YouTube
Cambrian Biopharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
James Peyer
  James Peyer LinkedIn Profile  James Peyer Twitter Account  James Peyer News  James Peyer on Facebook
Chief Operating Officer
Juliette Han
  Juliette Han LinkedIn Profile  Juliette Han Twitter Account  Juliette Han News  Juliette Han on Facebook
Executive Vice President
Georg Terstappen
  Georg Terstappen LinkedIn Profile  Georg Terstappen Twitter Account  Georg Terstappen News  Georg Terstappen on Facebook
Executive Vice President
Dennis Yamashita
  Dennis Yamashita LinkedIn Profile  Dennis Yamashita Twitter Account  Dennis Yamashita News  Dennis Yamashita on Facebook
VP - Bus. Development
Mark Nuttall
  Mark Nuttall LinkedIn Profile  Mark Nuttall Twitter Account  Mark Nuttall News  Mark Nuttall on Facebook
VP - General Counsel
Teri Champ
  Teri Champ LinkedIn Profile  Teri Champ Twitter Account  Teri Champ News  Teri Champ on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/27/2021: Admix venture capital transaction
Next: 10/27/2021: BackBox Software venture capital transaction

 

Share this article

 


About Database of VC Transactions

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary